Skip to main content

Phase II study of SEG101 in sickle cell disease patients with Prisprism (SPARTAN)

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Hematology

Awarded By

Novartis Pharmaceuticals Corporation

Start Date

March 18, 2020

End Date

June 30, 2024
 

Administered By

Medicine, Hematology

Awarded By

Novartis Pharmaceuticals Corporation

Start Date

March 18, 2020

End Date

June 30, 2024